Published: 19 Sep 2022 682 views
Outstanding candidates with a background in biomedical sciences, pharmacology, or pharmacy or similar are invited to apply for a fully funded PhD scholarship under the supervision of Dr Elinor Hortle and Prof Phil Hansbro at the Centre For Inflammation, Centenary institute.
Mast cells, synonymous with allergy, are long lived tissue resident immune cells. They are strategically located in the lungs where they can detect pathogens and release numerous proinflammatory mediators to recruit additional cells or aid in direct killing of invading pathogens. For these reasons, they may be ideal targets for host-directed therapies to treat respiratory pathogens.
This project will use genetically modified mice that are deficient in specific mast cell proteins to dissect the role that mast cells play in the host response to lung infection. Understanding more about these host-pathogen interactions may identify new ways to treat respiratory diseases.
UTS is the top-ranked young university in Australia. Our vision is to be a leading public university of technology recognised for our global impact. We’re known for our innovative teaching. We’re committed to practical innovation and research that benefits industry and society. We believe in social change to create a more just and equal world.
Application Deadline | Not Specified |
Country to study | Australia |
School to study | University of Technology Sydney |
Type | PhD |
Sponsor | University of Technology Sydney (UTS) |
Gender | Men and Women |
Partial Funding, $28,597 per year + additional funds ($7.5k) for travel and other PhD-related expenses.
Prospective candidates should contact Prof. Phil Hansbro for further information and to find out how to apply. Please include a CV and short description explaining your interest in the project. Shortlisted candidates will be advised with further details.